乌干达HIV感染儿童中微生物易位并未驱动免疫激活
该研究在CHAPAS-3试验的249名乌干达儿童中检测96周内19种免疫激活和炎症标志物,其中142名HIV感染、107名未感染。结果显示免疫激活随抗逆转录病毒治疗(ART)使用而下降,但血液细菌DNA水平在各组均低或阴性,微生物易位并未驱动免疫激活。
要点
- 在249名乌干达儿童中,HIV感染组142名、未感染对照组107名,检测19种免疫激活和炎症标志物。
- 免疫激活标志物可分为3个聚类,聚类1以HIV未感染儿童为主,聚类3以未治疗HIV感染儿童为主。
- 血液微生物DNA水平在各组均阴性或极低,微生物易位并未驱动免疫激活。
核心结论
- 免疫激活随ART使用而下降,标志物聚类提示免疫激活模式因HIV和ART状态而异;无论HIV状态、ART状态和免疫激活状态如何,血液细菌DNA水平均低;微生物易位未驱动免疫激活。
研究设计与样本
- 研究纳入CHAPAS-3试验中HIV感染的乌干达儿童及年龄匹配的HIV未感染对照,共249名儿童,其中HIV感染142名、未感染107名。
- 在96周内检测19种免疫激活和炎症标志物,并用分子技术(包括下一代测序)评估微生物易位。
主要发现
- 249名儿童中142名HIV感染,其中120名未接受过ART,中位年龄2.8岁(IQR 1.7-4.0岁),基线CD4+ T细胞百分比中位数20%(IQR 14%-24%);22名有ART经验,中位年龄6.5岁(IQR 5.9-9.2岁),基线CD4+ T细胞百分比中位数35%(IQR 31%-39%)。
- 未接受过ART的儿童第96周CD4+ T细胞百分比中位增加17个百分点(IQR 12-22个百分点);病毒载量<100 copies/mL者在未接受过ART儿童中占76%、在有ART经验儿童中占91%。
- 免疫激活随ART使用而下降;聚类1中多数儿童HIV未感染,聚类2为HIV未感染与HIV感染(未治疗或有ART经验)混合,聚类3中多数未接受过ART;免疫激活在聚类1低、在聚类3下降、在聚类2持续。
- 血液微生物DNA水平在各组均阴性或极低,除肠杆菌科外各聚类间无差异(肠杆菌科水平在聚类1更高,P < .0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Immune activation is associated with morbidity and mortality during human immunodeficiency virus (HIV) infection, despite receipt of antiretroviral therapy (ART). We investigated whether microbial translocation drives immune activation in HIV-infected Ugandan children. METHODS: Nineteen markers of immune activation and inflammation were measured over 96 weeks in HIV-infected Ugandan children in the CHAPAS-3 Trial and HIV-uninfected age-matched controls. Microbial translocation was assessed using molecular techniques, including next-generation sequencing. RESULTS: Of 249 children included, 142 were infected with HIV; of these, 120 were ART naive, with a median age of 2.8 years (interquartile range [IQR], 1.7-4.0 years) and a median baseline CD4+ T-cell percentage of 20% (IQR, 14%-24%), and 22 were ART experienced, with a median age of 6.5 years (IQR, 5.9-9.2 years) and a median baseline CD4+ T-cell percentage of 35% (IQR, 31%-39%). The control group comprised 107 children without HIV infection. The median increase in the CD4+ T-cell percentage was 17 percentage points (IQR, 12-22 percentage points) at week 96 among ART-naive children, and the viral load was <100 copies/mL in 76% of ART-naive children and 91% of ART-experienced children. Immune activation decreased with ART use. Children could be divided on the basis of immune activation markers into the following 3 clusters: in cluster 1, the majority of children were HIV uninfected; cluster 2 comprised a mix of HIV-uninfected children and HIV-infected ART-naive or ART-experienced children; and in cluster 3, the majority were ART naive. Immune activation was low in cluster 1, decreased in cluster 3, and persisted in cluster 2. Blood microbial DNA levels were negative or very low across groups, with no difference between clusters except for Enterobacteriaceae organisms (the level was higher in cluster 1; P < .0001). CONCLUSION: Immune activation decreased with ART use, with marker clustering indicating different activation patterns according to HIV and ART status. Levels of bacterial DNA in blood were low regardless of HIV status, ART status, and immune activation status. Microbial translocation did not drive immune activation in this setting. CLINICAL TRIALS REGISTRATION: ISRCTN69078957.
引用
- Fitzgerald FC, Lhomme E, Harris K, et al. Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV. J Infect Dis. 2019. PMID: 30107546. doi:10.1093/infdis/jiy495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。